Skip to Content

Pfizer CRZ 200 (Xalkori 200 mg)

Generic Name: crizotinib

Pill with imprint Pfizer CRZ 200 is Pink & White, Capsule-shape and has been identified as Xalkori 200 mg. It is supplied by Pfizer Inc..

Xalkori is used in the treatment of non-small cell lung cancer and belongs to the drug class multikinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Xalkori 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Pfizer CRZ 200

Xalkori 200 mg Pfizer CRZ 200

Xalkori

Generic Name
crizotinib
Imprint
Pfizer CRZ 200
Strength
200 mg
Color
Pink & White
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Multikinase inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Pfizer Inc.
National Drug Code (NDC)
00069-8141

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.